Stocks
What Is the Best Cannabis ETF to Buy?
Answer
Cannabis ETFs offer diversified exposure to the marijuana industry, but performance and holdings vary significantly. As of 2024, the three primary cannabis-focused ETFs are the AdvisorShares Pure US Cannabis ETF (MSOS), ETFMG Alternative Harvest ETF (MJ), and AdvisorShares Pure Cannabis ETF (YOLO).
MSOS focuses exclusively on US multi-state operators (MSOs) and has approximately $500 million in assets under management. Its top holdings typically include Curaleaf, Green Thumb Industries, Trulieve, and Cresco Labs. This ETF provides pure-play exposure to companies that could benefit most from federal cannabis legalization.
MJ, the oldest cannabis ETF launched in 2015, takes a broader approach with $300+ million AUM. It includes international cannabis companies, tobacco firms with cannabis exposure, and cannabis-adjacent businesses like hydroponic equipment manufacturers. Major holdings often include Canopy Growth, Tilray, and Scotts Miracle-Gro.
YOLO maintains a global focus with roughly $50 million AUM, investing in both US MSOs and international cannabis companies. It offers more concentrated exposure with typically 25-30 holdings versus MJ's 30+ positions.
Performance has been volatile across all cannabis ETFs. Since inception, these funds have experienced significant drawdowns, with peak-to-trough declines exceeding 70% during market downturns. MSOS has shown stronger recent performance due to improving fundamentals among US operators.
Key considerations include expense ratios (typically 0.70-0.85%), liquidity, and regulatory risk. Cannabis remains federally illegal in the US, creating ongoing uncertainty. These ETFs also cannot access traditional banking services, limiting operational efficiency.
**Disclaimer:** This analysis is for informational purposes only and does not constitute investment advice. Cannabis investments carry substantial risks including regulatory uncertainty, volatility, and potential total loss. Consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.